Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
On-demand vs Maintenance Esomeprazole for Non-erosive GERD
NCT00164840Phase 3Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- May 2003
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by The Chinese University of Hong Kong. Started May 2003; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00164840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00164840.